Alethea Capital Management LLC Takes Position in Tempus AI, Inc. $TEM

Alethea Capital Management LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, Holdings Channel reports. The firm purchased 31,554 shares of the company’s stock, valued at approximately $1,863,000. Tempus AI makes up 0.9% of Alethea Capital Management LLC’s portfolio, making the stock its 7th largest position.

Other large investors have also modified their holdings of the company. JPL Wealth Management LLC acquired a new position in shares of Tempus AI in the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC acquired a new stake in shares of Tempus AI during the 4th quarter worth $27,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Tempus AI during the 3rd quarter worth $38,000. Danske Bank A S purchased a new position in shares of Tempus AI in the 3rd quarter worth $48,000. Finally, Sunbelt Securities Inc. purchased a new position in shares of Tempus AI in the 3rd quarter worth $52,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CEO Ryan Fukushima sold 13,550 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total value of $597,148.50. Following the completion of the transaction, the chief executive officer directly owned 603,558 shares in the company, valued at $26,598,801.06. The trade was a 2.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Ryan M. Bartolucci sold 4,116 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total value of $181,392.12. Following the sale, the chief accounting officer owned 74,041 shares in the company, valued at $3,262,986.87. The trade was a 5.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 558,557 shares of company stock valued at $26,611,939. Corporate insiders own 24.26% of the company’s stock.

Analysts Set New Price Targets

TEM has been the subject of a number of research reports. HC Wainwright decreased their target price on Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a report on Monday, May 11th. Needham & Company LLC reiterated a “buy” rating and issued a $75.00 price target on shares of Tempus AI in a report on Monday, June 1st. TD Cowen boosted their price objective on Tempus AI from $65.00 to $68.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Morgan Stanley decreased their target price on Tempus AI from $85.00 to $70.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Finally, Wall Street Zen upgraded Tempus AI from a “sell” rating to a “hold” rating in a research note on Saturday. Nine research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of “Hold” and an average target price of $68.64.

Tempus AI Stock Up 4.7%

Shares of NASDAQ TEM opened at $48.59 on Tuesday. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. Tempus AI, Inc. has a 1 year low of $41.73 and a 1 year high of $104.32. The stock’s 50-day simple moving average is $48.95 and its 200-day simple moving average is $57.29. The firm has a market cap of $8.73 billion, a price-to-earnings ratio of -28.25 and a beta of 3.64.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The firm had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.Tempus AI’s revenue for the quarter was up 36.1% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.24) earnings per share. As a group, equities analysts anticipate that Tempus AI, Inc. will post -1.35 earnings per share for the current fiscal year.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.